Log in to save to my catalogue

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary interven...

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary interven...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9451664

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

About this item

Full title

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

Publisher

United States: John Wiley & Sons, Inc

Journal title

Clinical cardiology (Mahwah, N.J.), 2022-09, Vol.45 (9), p.913-920

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
The itAlian pRospective Study on CANGrELOr (ARCANGELO) was aimed to assess the safety of using cangrelor during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) in the daily practice.
Hypothesis
The safety of cangrelor after the transition to oral P2Y12 inhibitors was evaluated as the inci...

Alternative Titles

Full title

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9451664

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9451664

Other Identifiers

ISSN

0160-9289,1932-8737

E-ISSN

1932-8737

DOI

10.1002/clc.23878

How to access this item